Details for 2017753966
Up to date per 03.04.2026
Actions
Details for 2017753966
Granted/Registered
European Patent
26.12.2018 A
24.03.2021 B1
19.02.2016
US
201662297759 P
A61K 38/21 20060101AFI20191202BHEP
Owner
Eiger Biopharmaceuticals, Inc.2155 Park Boulevard Palo Alto, CA 94306US
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
MARTINS, Eduardo Brunoc/o Eiger Biopharmaceuticals, Inc. 2155 Park Boulevard Palo Alto California 94306US
Information about Fees